Flt3 Inhibitors Continue To Expand Treatment Opportunities In Acute Myeloid Leukemia

Summary

In this episode of our podcast, we dive deep into the world of Mark Levis, MD, PhD, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, talks on the use of FMS- tyrosine kinase ... Raoul Tibes, MD, PhD, physician-scientist at the University Hospital Head Gail Roboz, MD, a professor of medicine and director of the Clinical and Translational Alexander Perl, MD, University of Pennsylvania, Philadelphia, PA, discusses the role of The RATIFY trial (NCT00651261) showed that midostaurin, a This video is part of the HMP Education content archive and may include previously accredited educational material. While this ... ... randomized study they'd shown a superiority of the flitter Amir Fathi, MD, MPH, Massachusetts General Hospital Cancer Center, Boston, MA, gives an overview of the Fms related receptor ... Richard M. Stone, MD, Dana-Farber Cancer Institute, Harvard Medical School Eunice Wang, MD, Roswell Park Comprehensive Cancer Center, Buffalo, NY discusses the details of a Phase III trial ...